The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Images in Clinical Medicine
PreviousPrevious
Volume 330:826 March 24, 1994 Number 12
NextNext

Gingival Hypertrophy in Myelomonocytic Leukemia

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Figure 1


View larger version (26K):
[in this window]
[in a new window]
 
Figure 1. Gingival Hypertrophy in Myelomonocytic Leukemia.

A 36-year-old woman with chronic myelomonocytic leukemia had marked gingival hypertrophy, thought to be due to infiltration of the gingiva by leukemic cells. The patient presented with a white-cell count of 28,800 per cubic millimeter, with 23 percent monocytes and 2 percent monoblasts, a hematocrit of 20 percent, and a platelet count of 156,000 per cubic millimeter. Treatment with etoposide, idarubicin, and cytarabine resulted in a clinical remission, with resolution of the gingival lesions.

 


Stan H.M. van Uum, M.D.
University Hospital
Nijmegen 6500 HB, the Netherlands


Jo-Jan Keuning, M.D., Ph.D.
Saint Joseph Hospital
. . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.